These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 30689998

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apoptotic Effect of Galbanic Acid via Activation of Caspases and Inhibition of Mcl-1 in H460 Non-Small Lung Carcinoma Cells.
    Oh BS, Shin EA, Jung JH, Jung DB, Kim B, Shim BS, Yazdi MC, Iranshahi M, Kim SH.
    Phytother Res; 2015 Jun; 29(6):844-9. PubMed ID: 25753585
    [Abstract] [Full Text] [Related]

  • 3. Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4.
    Ahn DS, Lee HJ, Hwang J, Han H, Kim B, Shim B, Kim SH.
    Int J Mol Sci; 2018 May 16; 19(5):. PubMed ID: 29772677
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].
    Yang J, Chen SZ.
    Yao Xue Xue Bao; 2010 Oct 16; 45(10):1247-53. PubMed ID: 21348302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D, Kwon HY, Sohn EJ, Nam MS, Kim JH, Lee JC, Ryu SY, Park B, Kim SH.
    Cell Physiol Biochem; 2015 Oct 16; 36(3):1151-62. PubMed ID: 26111475
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
    Song J, Ko HS, Sohn EJ, Kim B, Kim JH, Kim HJ, Kim C, Kim JE, Kim SH.
    Bioorg Med Chem Lett; 2014 Feb 15; 24(4):1188-91. PubMed ID: 24461294
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.
    Ouyang W, Yang C, Zhang S, Liu Y, Yang B, Zhang J, Zhou F, Zhou Y, Xie C.
    Int J Oncol; 2013 Feb 15; 42(2):699-711. PubMed ID: 23258590
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
    Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G.
    Clin Cancer Res; 2002 Feb 15; 8(2):596-606. PubMed ID: 11839682
    [Abstract] [Full Text] [Related]

  • 13. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan 15; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 14. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
    Zhu HB, Huang XF, Hu JZ, Zhou W, Chen W, Chen LL, He C.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 15; 30(4):245-9. PubMed ID: 18788624
    [Abstract] [Full Text] [Related]

  • 15. Casticin induces caspase-mediated apoptosis via activation of mitochondrial pathway and upregulation of DR5 in human lung cancer cells.
    Zhou Y, Peng Y, Mao QQ, Li X, Chen MW, Su J, Tian L, Mao NQ, Long LZ, Quan MF, Liu F, Zhou SF, Zhao YX.
    Asian Pac J Trop Med; 2013 May 13; 6(5):372-8. PubMed ID: 23608376
    [Abstract] [Full Text] [Related]

  • 16. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S, Tripathi N, Preet R, Siddharth S, Nayak A, Bharatam PV, Kundu CN.
    Oncotarget; 2017 Jan 03; 8(1):248-267. PubMed ID: 27542249
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY, Hong M, Heo SH, Park S, Kwon TK, Sung YH, Oh Y, Lee S, Yi GS, Kim I.
    Mol Carcinog; 2018 Nov 03; 57(11):1492-1506. PubMed ID: 29964331
    [Abstract] [Full Text] [Related]

  • 18. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
    Lamothe B, Aggarwal BB.
    J Interferon Cytokine Res; 2002 Feb 03; 22(2):269-79. PubMed ID: 11911810
    [Abstract] [Full Text] [Related]

  • 19. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5.
    Kim EY, Yu JS, Yang M, Kim AK.
    Mol Cells; 2013 Jan 03; 35(1):32-40. PubMed ID: 23224239
    [Abstract] [Full Text] [Related]

  • 20. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells.
    Xie ZH, Quan MF, Liu F, Cao JG, Zhang JS.
    BMC Cancer; 2011 Jul 29; 11():322. PubMed ID: 21801359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.